People · Operator

Chase Grey Perry

Named in public records as an officer, director or promoter · active 2020–2022 · Healthtech

1
Companies
6
Filings
$29.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Modify Health LLCHealthtechSeries A$29.0M$58.8M2020
Operator network

Chase Grey Perry at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

RIK VANDEVENNE · 5 companies · 1 sharedRIK VANDEVENNEChase Perry · 4 companies · 1 sharedChase PerryH Grey Wood · 2 companies · 1 sharedH Grey WoodMichael Italiano · 2 companies · 1 sharedMichael ItalianoPete Desai · 2 companies · 1 sharedPete DesaiRik B Vandevenne · 2 companies · 1 sharedRik B VandevenneBen B Leedle · 1 companies · 1 sharedBen B LeedleBen Grey Leedle · 1 companies · 1 sharedBen Grey LeedleBen Leedle · 1 companies · 1 sharedBen LeedleChase B Perry · 1 companies · 1 sharedChase B PerryGeorge B Pratt · 1 companies · 1 sharedGeorge B PrattGeorge Pratt · 1 companies · 1 sharedGeorge PrattJames B Young · 1 companies · 1 sharedJames B YoungJames R Campbell · 1 companies · 1 sharedJames R CampbellScott B Ketover · 1 companies · 1 sharedScott B KetoverModify Health LLC · $29.0M raisedModify Health LLCChase Grey PerryCP
Chase Grey Perry Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Chase Grey Perry on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
RIK VANDEVENNE15
Chase Perry14
Rik B Vandevenne12
Michael Italiano12
Pete Desai12
H Grey Wood12
Chase B Perry11
Ben Leedle11
George B Pratt11
Ben B Leedle11
James R Campbell11
Scott B Ketover11
Ben Grey Leedle11
George Pratt11
James B Young11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.